» Articles » PMID: 23344255

Dystrophin Deficiency Leads to Disturbance of LAMP1-vesicle-associated Protein Secretion

Overview
Publisher Springer
Specialty Biology
Date 2013 Jan 25
PMID 23344255
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Duchenne muscular dystrophy results from loss of the protein dystrophin, which links the intracellular cytoskeletal network with the extracellular matrix, but deficiency in this function does not fully explain the onset or progression of the disease. While some intracellular events involved in the degeneration of dystrophin-deficient muscle fibers have been well characterized, changes in their secretory profile are undescribed. To analyze the secretome profile of mdx myotubes independently of myonecrosis, we labeled the proteins of mdx and wild-type myotubes with stable isotope-labeled amino acids (SILAC), finding marked enrichment of vesicular markers in the mdx secretome. These included the lysosomal-associated membrane protein, LAMP1, that co-localized in vesicles with an over-secreted cytoskeletal protein, myosin light chain 1. These LAMP1/MLC1-3-positive vesicles accumulated in the cytosol of mdx myotubes and were secreted into the culture medium in a range of abnormal densities. Restitution of dystrophin expression, by exon skipping, to some 30 % of the control value, partially normalized the secretome profile and the excess LAMP1 accumulation. Together, our results suggest that a lack of dystrophin leads to a general dysregulation of vesicle trafficking. We hypothesize that disturbance of the export of proteins through vesicles occurs before, and then concurrently with, the myonecrotic cascade and contributes chronically to the pathophysiology of DMD, thereby presenting us with a range of new potential therapeutic targets.

Citing Articles

EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method.

Hanson B, Vorobieva I, Zheng W, Conceicao M, Lomonosova Y, Mager I Mol Ther Nucleic Acids. 2023; 33:511-528.

PMID: 37602275 PMC: 10432918. DOI: 10.1016/j.omtn.2023.07.005.


Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers.

Johansson C, Hunt H, Signorelli M, Edfors F, Hober A, Svensson A Clin Proteomics. 2023; 20(1):23.

PMID: 37308827 PMC: 10258980. DOI: 10.1186/s12014-023-09412-1.


The secretome of skeletal muscle cells: A systematic review.

Florin A, Lambert C, Sanchez C, Zappia J, Durieux N, Tieppo A Osteoarthr Cartil Open. 2022; 2(1):100019.

PMID: 36474563 PMC: 9718214. DOI: 10.1016/j.ocarto.2019.100019.


Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.

Mollard A, Peccate C, Forand A, Chassagne J, Julien L, Meunier P Sci Rep. 2022; 12(1):9674.

PMID: 35690627 PMC: 9188557. DOI: 10.1038/s41598-022-13405-9.


The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes.

Anakor E, Milla V, Connolly O, Martinat C, Pradat P, Dumonceaux J Cells. 2022; 11(5).

PMID: 35269468 PMC: 8909615. DOI: 10.3390/cells11050845.


References
1.
Wooddell C, Zhang G, Griffin J, Hegge J, Huss T, Wolff J . Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice. Muscle Nerve. 2009; 41(4):487-99. DOI: 10.1002/mus.21527. View

2.
SCHAPIRA F, DREYFUS J . [SERUM CREATINE KINASE IN MYOPATHIC MICE]. Enzymol Biol Clin (Basel). 1963; 79:53-7. View

3.
Park S, Venable J, Xu T, Yates 3rd J . A quantitative analysis software tool for mass spectrometry-based proteomics. Nat Methods. 2008; 5(4):319-22. PMC: 3509211. DOI: 10.1038/nmeth.1195. View

4.
Kominami E, Kunio I, Katunuma N . Activation of the intramyofibral autophagic-lysosomal system in muscular dystrophy. Am J Pathol. 1987; 127(3):461-6. PMC: 1899763. View

5.
Millay D, Sargent M, Osinska H, Baines C, Barton E, Vuagniaux G . Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med. 2008; 14(4):442-7. PMC: 2655270. DOI: 10.1038/nm1736. View